EXTENTUS PHARMA LTD

Active Liverpool

Research and experimental development on biotechnology

2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

EXTENTUS PHARMA LTD

Research and experimental development on biotechnology

Founded 20 Mar 2014 Active Liverpool, England 2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

TANDEM NANO LTD 20 Mar 2014 — 6 Nov 2025
Accounts Submitted 30 Apr 2025 Next due 30 Apr 2026 10 days remaining
Confirmation Submitted 25 Apr 2025 Next due 3 Apr 2026 17 days overdue
Net assets £-1M £268K 2024 year on year
Total assets £260K £37K 2024 year on year
Total Liabilities £2M £305K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

11b Liverpool Science Park Ic1 Mount Pleasant Liverpool L3 5TF England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for EXTENTUS PHARMA LTD (08949503), an active life sciences and medical technology company based in Liverpool, England. Incorporated 20 Mar 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£230.91k

Increased by £186.77k (+423%)

Net Assets

-£1.29M

Decreased by £267.80k (-26%)

Total Liabilities

£1.55M

Increased by £305.14k (+25%)

Turnover

N/A

Employees

2

Debt Ratio

595%

Increased by 37 (+7%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Emma NolanDirectorBritishEngland5622 Jan 2018Active
Nicola Ann BroughtonDirectorBritishEngland541 Aug 2024Active

Shareholders

Shareholders (14)

University Of Liverpool
54.4%
Andrew Owen
15.7%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

University Of Liverpool

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
2 Mar 2026IncorporationMemorandum Articles
6 Nov 2025Change Of NameCertificate Change Of Name Company
30 Apr 2025AccountsAnnual accounts made up to 2024-07-31
25 Apr 2025Confirmation StatementConfirmation statement made on 2025-03-20 with no updates
20 Sept 2024OfficersAppointment of Dr Nicola Ann Broughton as director on 2024-08-01
2 Mar 2026 Incorporation

Memorandum Articles

6 Nov 2025 Change Of Name

Certificate Change Of Name Company

30 Apr 2025 Accounts

Annual accounts made up to 2024-07-31

25 Apr 2025 Confirmation Statement

Confirmation statement made on 2025-03-20 with no updates

20 Sept 2024 Officers

Appointment of Dr Nicola Ann Broughton as director on 2024-08-01

Recent Activity

Latest Activity

Memorandum Articles

1 months ago on 2 Mar 2026

Certificate Change Of Name Company

5 months ago on 6 Nov 2025

Annual accounts made up to 2024-07-31

11 months ago on 30 Apr 2025

Confirmation statement made on 2025-03-20 with no updates

11 months ago on 25 Apr 2025

Appointment of Dr Nicola Ann Broughton as director on 2024-08-01

1 years ago on 20 Sept 2024